54
Views
38
CrossRef citations to date
0
Altmetric
Original Article

Human Major Histocompatibility Complex Contains Several Leukemia Susceptibility Genes

, , , , , , , & show all
Pages 211-222 | Received 10 May 1993, Published online: 01 Jul 2009

References

  • Lilly F. Mouse leukemia: a model of a multiple gene disease. J. Natl. Cancer Inst. 1972; 49: 927–934
  • Vasmel W.L.B., Zijlstra M., Radaskiewicz T., Leupers C.J.M., De Goede R.E.V., Melief C.J.M. Major histocompatibility complex class II-regulated immunity to murine leukemia virus protects against early T- but not late B-cell lymphomas. J. Virol. 1988; 62: 3156–3166
  • Albright A.L., Gill T.J., III, Geyer S.J. Immunogenetic control of brain tumor growth in rats. Cancer Res. 1977; 37: 2512–2521
  • Melhem M.F., Kunz H.W., Gill IJ.T., II. Genetic control of susceptibility to diethylnitrosamine and di-methylbenzanthracene carcinogenesis in rats. Am. J. Pathol. 1991; 139: 45–51
  • Demant P., Oomen L. C. J. M., Oudshoorn-Snoek M. Genetics of tumour susceptibility in the mouse: MHC and non-MHC genes. Adv. Cancer Res. 1989; 53: 117–179
  • Collins W.M., Briles W.E., Zsigray R.M., Dunlop W.R., Corbett A.C., Clark K.K., Marks J.L., McGail T.P. The B locus (MHC) in the chicken: Association with the fate of RSV-induced tumors. Immunogenetics 1977; 5: 333–343
  • Han R., Breitburd F., Marche P.N., Orth G. Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class II genes. Nature 1992; 356: 66–68
  • Miyazawa M., Nishio J., Wehrly K., Chesebro B. Influence of MHC genes on spontaneous recovery from Friend retrovirus-induced leukemia. J. Immunol. 1992; 148: 644–647
  • Gill JT., III. Immunological and genetic factors influencing development and susceptibility to cancer. Genetica 1987; 73: 15–24
  • Lilly F. The effect of histocompatibility-2 type on response to the Friend leukemia virus in mice. J. Exp. Med. 1968; 127: 465–473
  • Mühlbock O., Dux A. Histocompatibility genes and mammary cancer in mice. Immunogenetics of the H-2 System, A. Lengerová, M Vojtiskova. Karger, Basel 1971; 123–127
  • Smith G.S., Walford R.L. Influence of the H-2 and H-l histocompatibility systems upon life span and spontaneous cancer incidences in congenic mice. Birth Defects 1978; 14: 281–312
  • Feingold N., Degos L., Feingold J. HLA in populations: an approach for genetical susceptibility to cancer. J. Immunogenet. 1979; 6: 29–35
  • Gatti R.A., Sparkes R.S., Field L.L., Spence M.A., Harris N.S., Freidin M. Genetic linkage analysis in a high-risk cancer family: HLA and 24 other markers. Cancer Genet. Cytogenet. 1983; 8: 9–18
  • Lynch H.T., Thomas R.J., Terasaki P.I., Ting A., Guir-Gis H.A., Kaplan A.R., Magee H., Lynch J., Kraft C., Chaperon E. HL-A in cancer family “N”. Cancer 1975; 36: 1315–1320
  • Hors J., Dausset J. HLA and susceptibility to Hodgkin's disease. Immunol. Rev. 1983; 70: 167–192
  • Lu S.J., Day N.E., Degos L.G., Lepage V., Wang P.-C., Chan S.-H., Simons M., McKnight B., Easton D., Zeng Y., De-The G. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 1990; 346: 470–471
  • Gerkins V.R., Ting A., Menck H.T., Casagrande J.T., Terasaki P.I., Pike M.C., Henderson B.E. HL-A heterozygosity as a genetic marker of long-term survival. J. Natl. Cancer Inst. 1974; 52: 1909–1911
  • Chan K.W., Pollack M.S., Braun D., Jr., O'Reilly R.J., Dupont B. Distribution of HLA genotypes in families of patients with acute leukemia. Transplantation 1982; 33: 613–615
  • Carpentier N.A., Jeannet M. Increased HLA-DR compatibility between patients with acute myeloid leukemia and their parents: implication for bone marrow transplantation. Transplant Proc. 1987; 19: 2644–2645
  • Bortin M.M., D'Amaro J., Bach F.H., Rimm A.A., Van Rood J.J. HLA association with leukemia. Blood 1987; 70: 227–232
  • Uno H., Kawano K., Matsuoka H., Tsuda K. HLA and adult T-cell leukaemia: HLA-linked genes controlling susceptibility to human T-cell leukaemia virus type I. Clin. Exp. Immunol. 1988; 71: 211–216
  • Seremetis S., Cuttner J., Winchester R. Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic la epitope. J. Clin. Invest. 1985; 76: 1391–1397
  • Nunez-Roldan A., Szer I., Toguchi T., Cuttner J., Winchester R. Association of certain la allotypes with the occurrence of chronic lymphocytic leukemia: recognition by a monoclonal anti-Ia reagent of a susceptibility determinant not in the DR series. J. Exp. Med. 1982; 156: 1872–1877
  • Budowle B., Acton R.T., Barger B.O., Blackstick R., Crisy W., Go R.C.P., Hunphrey G.B., Ragab A., Roper M., Vietti T., Dearth J. Properdin factor B and acute lymphoblastic leukemia (ALL). Cancer 1982; 50: 2369–2371
  • Dorak M.T., Burnett A.K. Major histocompatibility complex, t-complex, and leukemia. Cancer Causes Control 1992; 3: 273–282
  • Trowsdale J., Lee J., Carey J., Grosveld F., Bodmer J., Bodmer W. Sequences related to HLA-DRa chain on human chromosome 6: Restriction enzyme polymorphism detected with DCa chain probes. Proc. Natl. Acad. Sci. USA 1983; 80: 1972–1976
  • Bidwell J.L., Jarrold E.A. HLA-DR allogen-otyping using exon-specific DNA probes and application of rapid minigel methods. Mol. Immunol. 1986; 23: 1111–1116
  • Belt K.T., Carroll N.C., Porter R.R. The structural basis of the multiple forms of human complement component C4. Cell 1984; 36: 907–914
  • Morley J., Campbell R.D. Internal homologies of the Ba fragment from human complement component factor B, a class III MHC antigen. EMBO J. 1984; 3: 153–157
  • Milner C.M., Campbell R.D. Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics 1990; 32: 242–251
  • Strachan T., Dodge A.B., Smillie D., Dyer P.A., Sodoyer R., Jordan B.R., Harris R. An HLA-C-specific DNA probe. Immunogenetics 1986; 33: 115–120
  • Koller B.H., Sidwell B., DeMars R., Orr H.T. Isolation of HLA locus-specific DNA probes from the 3′-untranslated region. Proc. Natl. Acad. Sci. USA 1984; 81: 5175–5178
  • Chomey M.J., Sawada I., Gillespie G.A., Srivastava R., Pan J., Weissman S.M. Transcription analysis, physical mapping, and molecular characterization of a non-classical human leukocyte antigen class I gene. Mol. Cell. Biol. 1990; 10: 243–253
  • Dorak M.T., Chalmers E.A., Sproul A.M., Mills K.I., Wilson D.W., Galbraith I., Henderson N., Gibson B.E.S., Burnett A.K. MHC class III polymorphisms in selection of donors for BMT. Bone Marrow Transplant. 1993; 11: 37–41
  • Alper C.A., Awdeh Z.L., Raum D.D., Yunis E.J. Extended major histocompatibility complex haplotypes in man: role of alleles analogous to murine t mutants. Clin. Immunol. Immunopathol. 1982; 24: 276–285
  • Altman D.G. Practical Statistics for Medical Research. Chapman & Hall, London 1992
  • Bidwell J.L., Bignon J.D. DNA-RFLP methods and interpretation scheme for HLA-DR and -DQ typing. Eur. J. Immunogenet. 1991; 18: 5–22
  • Ratanachaiyavong S., Bidwell J.L., Bidwell E.A., McGregor A.M. Linkage disequilibrium between the HLA-DQA2 alleles and the HLA-DR/DQ complex. Hum. Immunol. 1991; 30: 136–139
  • Bontrop R.E., Walford R. RFLP standardization report for C4/TaqI. Immunobiology of HLA, B Dupont. Springer-Verlag, New York 1989; Vol. 1: 761–762
  • Fattallah D., Abbal M., Thomsen M., Cambon-Thomsen A., Campbell R.D. A DNA restriction fragment length polymorphism in the complement region of the human MHC shows an absolute correlation with polymorphism of complement factor B (Bf) defined by isoelectric focusing. J. Immunogenet. 1985; 12: 321–326
  • Baur M.P., Neugebauer M., Albert E.D. Reference tables of two-locus haplotype frequencies for all MHC marker loci. Histocompatibility Testing 1984, E.D. Albert, M.P. Baur, W.R. Mayr. Springer-Verlag, Berlin 1984; 677–712
  • Mayer S., Grange D., Tongio M.M., Hauptmann G., Klein J. Haplotype study of the HLA-A B, C, and Bf associations by the factorial correspondence analysis. J. Immunogenet. 1981; 8: 7–13
  • Partanen J., Milner C., Campbell R.D., Mäki M., Lipsanen V., Koskimies S. HLA-linked heat-shock protein 70 (HSP70–2) gene polymorphism and celiac disease. Tissue Antigens 1993; 41: 15–19
  • Dorak M.T., Wilson D.W., Galbraith I., Henderson N., Mills K.I., Burnett A.K. RFLP analysis of the HLA-B locus (abstract). Eur. J. Immunogenet. 1992; 19: 440
  • Hansen J.L., Kushner J.P. The HLA class 1 locus: analysis of RFLPs in hereditary hemochromatosis. Cytogenet. Cell. Genet. 1989; 50: 216–219
  • Shukla H., Gillespie G.A., Srivastava R., Collins F., Chorney M.J. A class 1 jumping clone places the HLA-G gene approximately 100 kilobases from HLA-H within the HLA-A subregion of the human MHC. Genomics 1991; 10: 905–914
  • Cowan E.P., Jordan B.R., Coligan J.E. Molecular cloning and DNA sequence analysis of genes encoding cytotoxic T lymphocyte-defined HLA-A3 subtypes: The E1 subtype. J. Immunol. 1985; 135: 2835–2841
  • Albert E.D., Mickey M.R., Terasaki P.I. Deduction of 2140 HL-A haplotypes and segregation analysis in 535 families. Transplant Proc. 1973; 5: 215–221
  • Albert E.D., Nisperos B., Thomas E.D. HLA antigens and haplotypes in acute leukemia. Leuk. Res. 1977; 1: 261–269
  • Moor DeP. Distribution of HLA genotypes in sibs of patients with acute lymphoblastic leukemia. Eur. J. Haematol. 1989; 42: 317–318
  • Dorak M.T., Gaffney D., Wilson D., Galbraith I., Henderson N., Mills K.I., Burnett A.K. Are there human t-haplotypes? (abstract). Eur. J. Immunol. 1992; 19: 444
  • Björkhölm M., Holm G., Johansson B., Mellstedt H., Moller E. A prospective study of HL-A antigen phe-notypes and lymphocyte abnormalities in Hodgkin's disease. Tissue Antigens 1975; 6: 247–256
  • Kantor A.F., McLaughlin J.K., Blatner W.A., Bach F.H., Blot W.J., Schuman L.M., Fraumeni J.F, Jr. HLA antigens in renal cell carcinoma. Cancer Res. 1983; 43: 2330–2333
  • Sridama V., Hara Y., Fauchet R., Degroot L.J. Association of differentiated thyroid carcinoma with HLA-DR7. Cancer 1985; 56: 1086–1088
  • Wank R., Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 1991; 352: 723–725
  • Roos M.H., Demant P. Murine complement factor B (BF): sexual dimorphism and H-2 linked polymorphism. Immunogenetics 1982; 15: 23–30
  • Degos L., Drolet Y., Dausset J. HL-A antigens in chronic myeloid leukemia (CML) and chronic lymphoid leukemia (CLL). Transplant Proc. 1971; 3: 1309–1310
  • Hester J.P., Rossen R., Trujillo J., McCredie K.B., Freireich E.J. Frequency of HLA antigens in chronic myelocytic leukemia. South. Med. J. 1977; 70: 691–693
  • Zijlstra M., Melief C.J.M. Virology, genetics and immunology of murine lymphomagenesis. BBA 1986; 865: 197–231
  • Lilly F., Boyse E.A., Old L.J. Genetic basis of susceptibility to viral leukaemogenesis. Lancet 1964; ii: 1207–1209
  • Gelman R., Watson A., Yunis E., Williams R.M. Genetics of survival in mice: Subregions of the major histocompatibility complex. Genetics 1990; 125: 167–174
  • Matsuyama T., Schwenzer J., Silver J., Winchester R. Structural relationships between the DRB1 and DR62 subunits in DR 4, 7, and w9 haplotypes and the DRw53 (MT3) specificity. J. Immunol. 1986; 137: 934–940
  • Miyazawa M., Nishio J., Wehrly K., David C.S., Chesebro B. Spontaneous recovery from Friend re-trovirus-induced leukemia. Mapping of the Rfv-2 gene in the Q/TL region of the mouse MHC. J. Immunol. 1992; 148: 1964–1967
  • Miyazawa M., Nishio J., Wehrly K., Jay G., Melvold R.W., Chesebro B. Detailed mapping of the Rfv-1 gene that influences spontaneous recovery from Friend retro-virus-induced leukaemia. Eur. J. Immunogenet. 1992; 19: 159–164
  • Heasman M.A., Kemp I.W., MacLaren A.-M., Trotter P., Gillis C.R., Hole D.J. Incidence of leukaemia in young persons in west of Scotland (letter). Lancet 1984; i: 1188–1189
  • Jazwinska E.C., Kilpatrick D.C., Smart G.E., Liston W.A. Feto-maternal HLA compatibility does not have a major influence on human pregnancy except for lympho-cytotoxin production. Clin. Exp. Immunol. 1987; 68: 116–122
  • Ha H., Howard C.A., Yeom Y.I., Abe H., Artzt K., Bennett D. Several testis-expressed genes in the mouse t-complex have expression differences between wild-type and t-mutant mice. Dev. Genet. 1991; 12: 318–332

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.